パーキンソン病向け血液ベースバイオマーカーの世界市場、規模、シェア、産業分析レポート：バイオマーカータイプ別、用途別、技術プラットフォーム別、エンドユーザー別、地域別 - 市場予測（2025年～2034年）

Polaris Market Researchの最新調査によると、世界のパーキンソン病向け血液ベースバイオマーカーの市場規模は、2034年までに27億1,191万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

パーキンソン病向け血液ベースバイオマーカーは、血液中で検出可能な分子指標であり、疾患の存在、進行、治療反応に関する洞察を提供します。これらのバイオマーカーは、対症療法からタイムリーな介入と予防への移行を目指し、ヘルスケアシステムが早期発見に重点を置くにつれて注目を集めています。低侵襲な診断アプローチに対する需要の高まりは、臨床研究者や診断開発者に、パーキンソン病を早期段階で同定できる血液ベースのアッセイの開発を促しています。この動向は、パーキンソン病と類似の神経変性疾患との鑑別におけるバイオマーカーの有用性に関する臨床医の意識の高まりにも支えられています。

パーキンソン病向け血液ベースバイオマーカー市場は、バイオマーカーの発見と検証を強化するためのマルチオミクス技術の統合によって形成されています。ゲノミクス、プロテオミクス、メタボロミクスの進歩により、パーキンソン病を分子レベルでより包括的に理解できるようになり、特異性と感度が向上した新規の血液ベースバイオマーカーの同定につながっています。このようなテクノロジーと臨床研究の融合により、バイオマーカー開発のペースが加速し、臨床試験や個別化医療への応用も拡大しています。その結果、市場は精密主導型のデータ活用型診断ソリューションへと急速に進化しています。

パーキンソン病向け血液ベースバイオマーカー市場レポートのハイライト

用途別では、診断バイオマーカーセグメントが2024年に2億410万米ドルで売上高をリードしました。

バイオマーカータイプ別に見ると、NfLバイオマーカーセグメントは、複数の神経疾患における感度の高い神経変性の指標として有用性が確立されていることから、予測期間中に最も高いCAGR19.00%を記録すると予測されています。

北米は2024年に45.00%の世界シェアを占めましたが、これは先進的なヘルスケアシステムと主要バイオマーカー開発者および研究機関の集中的な存在によるものです。

アジア太平洋市場は、生物医学研究への投資、診断サービスの強化、疾患に対する啓発キャンペーンの高まりなどを背景に、2025年～2034年にCAGR20.50%を記録すると予想されます。

パーキンソン病向け血液ベースバイオマーカー市場における世界の主要企業には、Abbott Laboratories、Adx Neurosciences、Alamar Biosciences、betaSENSE、F. Hoffmann-La Roche Ltd、Merck KGaA、Proteome Sciences、QIAGEN N.V.、Quanterix Corporation、Thermo Fisher Scientific Inc.などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 パーキンソン病向け血液ベースバイオマーカーの世界市場分析

• 市場スナップショット
• パーキンソン病向け血液ベースバイオマーカー市場の力学
  • 促進要因と機会
    • パーキンソン病の有病率の上昇
    • バイオマーカーの発見と検証の進歩
  • 抑制要因と課題
    • 標準化と臨床検証の欠如
• PESTEL分析
• パーキンソン病向け血液ベースバイオマーカー市場の動向
• バリューチェーン分析

第5章 パーキンソン病向け血液ベースバイオマーカーの世界市場：バイオメーカータイプ別

• 主な調査結果
• イントロダクション
• α-シヌクレイン（α-Syn）
• 神経フィラメント軽鎖（NfL）
• 炎症マーカー
• 代謝バイオマーカー
• その他

第6章 パーキンソン病向け血液ベースバイオマーカーの世界市場：用途別

• 主な調査結果
• イントロダクション
• 診断バイオマーカー
• 予後バイオマーカー
• バイオマーカーのモニタリング
• 治療反応バイオマーカー
• その他

第7章 パーキンソン病向け血液ベースバイオマーカーの世界市場：技術プラットフォーム別

• 主な調査結果
• イントロダクション
• α-シヌクレインシーディング増幅アッセイ（aSyn-SAA）
• ELISAベースのアッセイ
• 免疫測定
• 質量分析
• その他

第8章 パーキンソン病向け血液ベースバイオマーカーの世界市場：エンドユーザー別

• 主な調査結果
• イントロダクション
• 病院と診療所
• 診断検査室
• 研究機関
• 製薬会社

第9章 パーキンソン病向け血液ベースバイオマーカーの世界市場：地域別

• 主な調査結果
• イントロダクション
  • パーキンソン病向け血液ベースバイオマーカー市場の評価：地域別、2020年～2034年
• 北米
  • 北米：バイオメーカータイプ別、2020～2034年
  • 北米：用途別、2020～2034年
  • 北米：技術プラットフォーム別、2020～2034年
  • 北米：エンドユーザー別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：バイオメーカータイプ別、2020～2034年
  • 欧州：用途別、2020～2034年
  • 欧州：技術プラットフォーム別、2020～2034年
  • 欧州：エンドユーザー別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋：バイオメーカータイプ別、2020～2034年
  • アジア太平洋：用途別、2020～2034年
  • アジア太平洋：技術プラットフォーム別、2020～2034年
  • アジア太平洋：エンドユーザー別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ
  • 中東・アフリカ：バイオメーカータイプ別、2020～2034年
  • 中東・アフリカ：用途別、2020～2034年
  • 中東・アフリカ：技術プラットフォーム別、2020～2034年
  • 中東・アフリカ：エンドユーザー別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アアフリカ
• ラテンアメリカ
  • ラテンアメリカ：バイオメーカータイプ別、2020～2034年
  • ラテンアメリカ：用途別、2020～2034年
  • ラテンアメリカ：技術プラットフォーム別、2020～2034年
  • ラテンアメリカ：エンドユーザー別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 事業拡大・買収分析
  • 事業拡大
  • 買収
• 提携/協業/協定/公開

第11章 企業プロファイル

• Abbott Laboratories
• Adx Neurosciences
• Alamar Biosciences
• betaSENSE
• F. Hoffmann-La Roche Ltd
• Merck KGaA
• Merck KGaA
• QIAGEN N.V.
• Quanterix Corporation
• Thermo Fisher Scientific Inc.

List of Tables:

• Table 1 Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 2 Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 3 Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 4 Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 5 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 6 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 7 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 8 North America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 9 US: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 10 US: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 11 US: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 12 US: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 13 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 14 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 15 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 16 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 17 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 18 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 19 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 20 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 21 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 22 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 23 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 24 UK: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 25 France: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 26 France: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 27 France: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 28 France: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 29 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 30 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 31 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 32 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 33 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 34 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 35 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 36 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 37 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 38 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 39 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 40 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 41 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 42 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 43 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 44 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 45 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 46 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 47 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 48 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 57 China: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 58 China: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 59 China: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 60 China: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 61 India: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 62 India: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 63 India: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 64 India: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 65 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 66 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 67 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 68 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 69 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 70 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 71 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 72 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 73 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 74 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 75 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 76 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 77 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 78 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 79 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 80 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 81 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 82 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 83 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 84 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 97 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 98 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 99 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 100 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 101 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 102 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 103 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 104 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 105 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 106 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 107 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 108 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 113 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 114 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 115 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 116 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 117 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 118 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 119 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 120 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 121 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 122 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 123 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 124 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 125 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 126 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 127 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 128 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Blood-Based Biomarker for Parkinson's Disease Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Biomaker Type
• Figure 7. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2024 & 2034 (USD Billion)
• Figure 8. Market by Application
• Figure 9. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2024 & 2034 (USD Billion)
• Figure 10. Market by Technology Platform
• Figure 11. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2024 & 2034 (USD Billion)
• Figure 12. Market by End User
• Figure 13. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2024 & 2034 (USD Billion)
• Figure 14. Global Blood-Based Biomarker for Parkinson's Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
• Figure 15. Strategic Analysis - Global Blood-Based Biomarker for Parkinson's Disease Market

The blood-based biomarker for Parkinson's disease market size is expected to reach USD 2,711.91 million by 2034, according to a new study by Polaris Market Research. The report "Blood-Based Biomarker for Parkinson's Disease Market Share, Size, Trends, Industry Analysis Report By Biomarker Type [Alpha-Synuclein (a-syn), Neurofilament Light Chain (Nfl)], By Application, By Technology Platform, By End User, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Blood-based biomarkers for Parkinson's disease are molecular indicators detectable in blood that provide insights into the presence, progression, and therapeutic response of the disease. These biomarkers are gaining prominence as healthcare systems focus on early-stage detection, aiming to shift from symptomatic treatment to timely intervention and prevention. The growing demand for minimally invasive diagnostic approaches is encouraging clinical researchers and diagnostic developers to advance blood-based assays capable of identifying Parkinson's at its earliest stages. This trend is also being supported by rising awareness among clinicians regarding the utility of biomarkers in differentiating Parkinson's from similar neurodegenerative disorders.

The blood-based biomarker for Parkinson's disease market is shaped by the integration of multi-omics technologies to enhance biomarker discovery and validation. Advances in genomics, proteomics, and metabolomics are enabling a more comprehensive understanding of Parkinson's disease at the molecular level, leading to the identification of novel blood-based biomarkers with improved specificity and sensitivity. This convergence of technology and clinical research is accelerating the pace of biomarker development and also expanding their applicability in clinical trials and personalized medicine. As a result, the market is evolving rapidly toward precision-driven, data-enabled diagnostic solutions.

Blood-Based Biomarker for Parkinson's Disease Market Report Highlights

In terms of application, the diagnostic biomarkers segment led revenue generation with USD 204.10 million in 2024, due to their critical role in detecting Parkinson's during early/prodromal stages when intervention is most impactful.

Based on biomarker type, the NfL biomarker segment is projected to register the highest CAGR of 19.00% during the forecast period, owing to its established utility as a sensitive neurodegeneration indicator across multiple neurological disorders.

North America held a 45.00% global share in 2024, benefiting from its advanced healthcare systems and the concentrated presence of leading biomarker developers and research institutions.

The market in Asia Pacific is expected to register a CAGR of 20.50% from 2025 to 2034, driven by investments in biomedical research, enhancements in diagnostic services, and rising awareness campaigns for diseases.

A few global key players in the blood-based biomarker for Parkinson's disease market include Abbott Laboratories, Adx Neurosciences, Alamar Biosciences, betaSENSE, F. Hoffmann-La Roche Ltd, Merck KGaA, Proteome Sciences, QIAGEN N.V., Quanterix Corporation, and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the blood-based biomarker for Parkinson's disease market report on the basis of biomarker type, application, technology platform, end user, and region:

By Biomarker Type Outlook (Revenue, USD Million, 2020-2034)

Alpha-Synuclein (a-Syn)

Neurofilament Light Chain (NfL)

Inflammatory Markers

Metabolic Biomarkers

Others

By Application Outlook (Revenue, USD Million, 2020-2034)

Diagnostic Biomarkers

Prognostic Biomarkers

Monitoring Biomarkers

Therapeutic Response Biomarkers

Others

By Technology Platform Outlook (Revenue, USD Million, 2020-2034)

Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA)

ELISA-Based Assays

Immunoassays

Mass Spectrometry

Others

By End User Outlook (Revenue, USD Million, 2020-2034)

Hospitals and Clinics

Diagnostic Laboratories

Research Institutes

Pharmaceutical Companies

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Blood-Based Biomarker for Parkinson's Disease Market Insights

• 4.1. Blood-Based Biomarker for Parkinson's Disease Market - Market Snapshot
• 4.2. Blood-Based Biomarker for Parkinson's Disease Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Prevalence of Parkinson's Disease
    • 4.2.1.2. Advancements in Biomarker Discovery and Validation
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Lack of Standardization and Clinical Validation
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Blood-Based Biomarker for Parkinson's Disease Market Trends
• 4.6. Value Chain Analysis

5. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
• 5.3. Alpha-Synuclein (a-Syn)
  • 5.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Alpha-Synuclein (a-Syn), by Region, 2020-2034 (USD Billion)
• 5.4. Neurofilament Light Chain (NfL)
  • 5.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Neurofilament Light Chain (NfL), by Region, 2020-2034 (USD Billion)
• 5.5. Inflammatory Markers
  • 5.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Inflammatory Markers, by Region, 2020-2034 (USD Billion)
• 5.6. Metabolic Biomarkers
  • 5.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Metabolic Biomarkers, by Region, 2020-2034 (USD Billion)
• 5.7. Others
  • 5.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
• 6.3. Diagnostic Biomarkers
  • 6.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Diagnostic Biomarkers, by Region, 2020-2034 (USD Billion)
• 6.4. Prognostic Biomarkers
  • 6.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Prognostic Biomarkers, by Region, 2020-2034 (USD Billion)
• 6.5. Monitoring Biomarkers
  • 6.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Monitoring Biomarkers, by Region, 2020-2034 (USD Billion)
• 6.6. Therapeutic Response Biomarkers
  • 6.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Therapeutic Response Biomarkers, by Region, 2020-2034 (USD Billion)
• 6.7. Others
  • 6.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
• 7.3. Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA)
  • 7.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA), by Region, 2020-2034 (USD Billion)
• 7.4. ELISA-Based Assays
  • 7.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by ELISA-Based Assays, by Region, 2020-2034 (USD Billion)
• 7.5. Immunoassays
  • 7.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Immunoassays, by Region, 2020-2034 (USD Billion)
• 7.6. Mass Spectrometry
  • 7.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
• 7.7. Others
  • 7.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• 8.3. Hospitals and Clinics
  • 8.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Billion)
• 8.4. Diagnostic Laboratories
  • 8.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
• 8.5. Research Institutes
  • 8.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Research Institutes, by Region, 2020-2034 (USD Billion)
• 8.6. Pharmaceutical Companies
  • 8.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)

9. Global Blood-Based Biomarker for Parkinson's Disease Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Blood-Based Biomarker for Parkinson's Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Blood-Based Biomarker for Parkinson's Disease Market - North America
  • 9.3.1. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  • 9.3.3. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  • 9.3.4. North America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.3.5. Blood-Based Biomarker for Parkinson's Disease Market - US
    • 9.3.5.1. US: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.3.6. Blood-Based Biomarker for Parkinson's Disease Market - Canada
    • 9.3.6.1. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• 9.4. Blood-Based Biomarker for Parkinson's Disease Market - Europe
  • 9.4.1. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.4.5. Blood-Based Biomarker for Parkinson's Disease Market - UK
    • 9.4.5.1. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.4.6. Blood-Based Biomarker for Parkinson's Disease Market - France
    • 9.4.6.1. France: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.4.7. Blood-Based Biomarker for Parkinson's Disease Market - Germany
    • 9.4.7.1. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.4.8. Blood-Based Biomarker for Parkinson's Disease Market - Italy
    • 9.4.8.1. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.4.9. Blood-Based Biomarker for Parkinson's Disease Market - Spain
    • 9.4.9.1. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.4.10. Blood-Based Biomarker for Parkinson's Disease Market - Netherlands
    • 9.4.10.1. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.4.11. Blood-Based Biomarker for Parkinson's Disease Market - Russia
    • 9.4.11.1. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.4.12. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• 9.5. Blood-Based Biomarker for Parkinson's Disease Market - Asia Pacific
  • 9.5.1. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.5.5. Blood-Based Biomarker for Parkinson's Disease Market - China
    • 9.5.5.1. China: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.5.6. Blood-Based Biomarker for Parkinson's Disease Market - India
    • 9.5.6.1. India: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.5.7. Blood-Based Biomarker for Parkinson's Disease Market - Malaysia
    • 9.5.7.1. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.5.8. Blood-Based Biomarker for Parkinson's Disease Market - Japan
    • 9.5.8.1. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.5.9. Blood-Based Biomarker for Parkinson's Disease Market - Indonesia
    • 9.5.9.1. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.5.10. Blood-Based Biomarker for Parkinson's Disease Market - South Korea
    • 9.5.10.1. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.5.11. Blood-Based Biomarker for Parkinson's Disease Market - Australia
    • 9.5.11.1. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.5.12. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• 9.6. Blood-Based Biomarker for Parkinson's Disease Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.6.5. Blood-Based Biomarker for Parkinson's Disease Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.6.6. Blood-Based Biomarker for Parkinson's Disease Market - UAE
    • 9.6.6.1. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.6.7. Blood-Based Biomarker for Parkinson's Disease Market - Israel
    • 9.6.7.1. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.6.8. Blood-Based Biomarker for Parkinson's Disease Market - South Africa
    • 9.6.8.1. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.6.9. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
• 9.7. Blood-Based Biomarker for Parkinson's Disease Market - Latin America
  • 9.7.1. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.7.5. Blood-Based Biomarker for Parkinson's Disease Market - Mexico
    • 9.7.5.1. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.7.6. Blood-Based Biomarker for Parkinson's Disease Market - Brazil
    • 9.7.6.1. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.7.7. Blood-Based Biomarker for Parkinson's Disease Market - Argentina
    • 9.7.7.1. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
  • 9.7.8. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott Laboratories
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Adx Neurosciences
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Alamar Biosciences
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. betaSENSE
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. F. Hoffmann-La Roche Ltd
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Merck KGaA
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Merck KGaA
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. QIAGEN N.V.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Quanterix Corporation
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Thermo Fisher Scientific Inc.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development